RECRUITING

Atlantic Lipid Lowering Treatment Optimization Program

Description

Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.

Study Overview

Study Details

Study overview

Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.

Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Complex Dyslipidemias

Atlantic Lipid Lowering Treatment Optimization Program

Condition
Familial Hypercholesterolemia
Intervention / Treatment

-

Contacts and Locations

Clark

Atlantic Medical Group, Clark, New Jersey, United States, 07066

Springfield

Atlantic Medical Group, Springfield, New Jersey, United States, 07081

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * LDL-C ≥160 mg/dL
  • * Untreated LDL-C ≥190 with family history of CAD
  • * Prior MI and currently without optimized lipid-lowering therapy
  • * Family history of CAD in first degree relative
  • * Personal history of CAD
  • * Untreated triglycerides \>500
  • * Elevated Lp(a) and/or high calcium scores
  • * Consenting individuals
  • * Individuals who are pregnant
  • * Individuals who are incarcerated
  • * Individuals with a terminal illness
  • * Individuals who do not consent

Ages Eligible for Study

18 Years to 120 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Atlantic Health System,

Robert D Fishberg, MD, PRINCIPAL_INVESTIGATOR, Atlantic Health System

Study Record Dates

2027-12-31